Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Animal Vaccine Market 

5.1. COVID-19 Landscape: Animal Vaccine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Animal Vaccine Market, By Product Type

8.1. Animal Vaccine Market Revenue and Volume Forecast, by Product Type, 2023-2032

8.1.1. Attenuated Live Vaccines

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Inactivated Vaccines

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Subunit Vaccines

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. DNA Vaccines

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

8.1.5. Recombinant Vaccines

8.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Animal Vaccine Market, By Animal Type

9.1. Animal Vaccine Market Revenue and Volume Forecast, by Animal Type, 2023-2032

9.1.1. Livestock

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Companion

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Animal Vaccine Market, By Route of Administration 

10.1. Animal Vaccine Market Revenue and Volume Forecast, by Route of Administration, 2023-2032

10.1.1. Subcutaneous

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Intramuscular

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Intranasal

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Animal Vaccine Market, By End User 

11.1. Animal Vaccine Market Revenue and Volume Forecast, by End User, 2023-2032

11.1.1. Hospital

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. clinics

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Animal Vaccine Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

Chapter 13. Company Profiles

13.1. Merck & Co., Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Zoetis

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Boehringer Ingelheim International GmbH

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Virbac

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Biogénesis Bagó

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Indian Immunologicals Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Elanco

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Ceva

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Phibro Animal Health Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Neogen Corporation

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms